/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | SFESSAFEGUARD SCIENTIFIC |
|---|---|
| Last close | no stored close |
| Change % | no stored close |
| Market cap | no stored close |
| P/E | no stored close |
| Revenue | $35M⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenues As ofFY ending 2009-12-31 Filing10-K · 0001193125-12-094470 · filed 2012-03-02 Open the filing on EDGAR →Open the XBRL payload →CiteSAFEGUARD SCIENTIFICS INC (SFES), us-gaap:Revenues: 34,839,000 USD, fiscal year ended 2009-12-31. Form 10-K, accession 0001193125-12-094470, filed 2012-03-02. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0000086115/us-gaap/Revenues.json |
| Rev growth (YoY) | no prior year filed |
| Net income | $-9828000⊙INFERENCE — derived by arithmetic SourceSEC XBRL companyfacts FieldProfitLoss As ofTTM ending 2023-12-31 Filing10-K · 0001437749-24-009415 · filed 2024-03-26 HowSum of the last four filed quarters: arithmetic on filed figures, no estimates. Open the filing on EDGAR →Open the XBRL payload →CiteSAFEGUARD SCIENTIFICS INC (SFES), us-gaap:ProfitLoss: -9,828,000 USD, trailing twelve months ended 2023-12-31, the sum of four filed quarters. Newest quarter from Form 10-K, accession 0001437749-24-009415, filed 2024-03-26. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0000086115/us-gaap/ProfitLoss.json |
| Net margin | periods differ |
| EPS (diluted) | $-0.61⊙INFERENCE — derived by arithmetic SourceSEC XBRL companyfacts FieldEarningsPerShareDiluted As ofTTM ending 2023-12-31 Filing10-K · 0001437749-24-009415 · filed 2024-03-26 HowSum of the last four filed quarters: arithmetic on filed figures, no estimates. Open the filing on EDGAR →Open the XBRL payload →CiteSAFEGUARD SCIENTIFICS INC (SFES), us-gaap:EarningsPerShareDiluted: -0.61 USD per share, trailing twelve months ended 2023-12-31, the sum of four filed quarters. Newest quarter from Form 10-K, accession 0001437749-24-009415, filed 2024-03-26. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0000086115/us-gaap/EarningsPerShareDiluted.json |
| Piotroski F-ScoreUNVALIDATED | not scored |
| Altman Z-ScoreUNVALIDATED | not scored |
| Beneish M-ScoreUNVALIDATED | not scored |
| Next earnings | rep. 11-02 |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Each cell names its period. A ratio row reads not comparable when the companies’ periods differ by more than six weeks or mix a fiscal year with a trailing twelve months, and a figure more than a year older than the company’s newest period is marked older period. No row ranks the companies. Educational only, not investment advice.